Roberta J Seidman MD
Cytopathology, Neuropathology
Associate Professor, Pathology (Clinical), Stony Brook University SOM
Join to View Full Profile
Nicolls RdStony Brook, NY 11794
Phone+1 631-444-2227
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Roberta Seidman, MD is a board certified pathologist in Stony Brook, New York. She is currently licensed to practice medicine in New York. She is an Associate Professor at Stony Brook University SOM.
Education & Training
Stony Brook MedicineFellowship, Neuropathology, 1987 - 1990- Stony Brook Medicine/University HospitalResidency, Neurology, 1984 - 1987
- Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1983 - 1984
Stony Brook University Health Sciences Center School of MedicineClass of 1983
Certifications & Licensure
NY State Medical License 1984 - 2027
American Board of Pathology Neuropathology
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 4 citationsDiffuse midline glioma, H3K27-altered, of the conus medullaris presenting as acute urinary retention: illustrative case.Sabir Saluja, Bayan Razzaq, John A Servider, Roberta Seidman, Harry Mushlin
Journal of Neurosurgery. Case Lessons. 2023-04-17 - Bilateral microsporidial keratoconjunctivitis in a clinically healthy female receiving intravitreal steroid injections: Associations and potential risk factors.Timothy Y Chou, Jahnvi Bansal, Roberta Seidman, Afra Rahman, Delia Montalto
American Journal of Ophthalmology Case Reports. 2022-09-01 - 1 citationsReply to I. Nishino and J. TanboonJonathan Perk, Yaacov Anziska, Roberta Seidman
Muscle & Nerve. 2020-10-23
Press Mentions
- Immune Checkpoint Inhibitors & Immune-Related Adverse EventsSeptember 20th, 2018
